Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Carteolol hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carteolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carteolol hydrochloride 20 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carteolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely carteolol hydrochloride 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carteolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely carteolol hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carteolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carteolol hydrochloride 1% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carteolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ophthalmic carteolol hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carteolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carteolol hydrochloride 1% eye drops (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carteolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely carteolol hydrochloride 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carteolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carteolol hydrochloride 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Carteolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carteolol hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Carteolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carteolol hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Carteolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carteolol hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Carteolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely carteolol hydrochloride 2.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Carteolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carteolol hydrochloride 1% eye drops (substance) |
Has precise active ingredient |
True |
Carteolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carteolol hydrochloride 1% eye drops (substance) |
Has basis of strength substance (attribute) |
True |
Carteolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carteolol hydrochloride 20 mg/mL eye drops |
Has basis of strength substance (attribute) |
True |
Carteolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Carteolol hydrochloride 20 mg/mL eye drops |
Has precise active ingredient |
True |
Carteolol hydrochloride (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |